Chen Katz, MIGAL’s biotechnology group leader, has announced that researchers at the Israeli research institute has found an effective vaccine against coronavirus infection and would soon create a human vaccine against coronavirus (COVID-19), the Cables reports.
The institute also announced that the vaccine would be in oral form.
“Given the urgent global need for a human coronavirus vaccine, we are doing everything we can to accelerate development. Our goal is to produce the vaccine during the next 8-10 weeks, and to achieve safety approval in 90 days,” David Zigdon, MIGAL’s chief executive officer, said.
“This will be an oral vaccine, making it particularly accessible to the general public. We are currently in intensive discussions with potential partners that can help accelerate the in-human trials phase and expedite the completion final product development and regulatory activities.”